These MetAlert mice, together with loss‐ and gain‐of‐function studies in melanoma cell lines and histopathological studies in human clinical biopsies, ultimately identified the growth factor Midkine (MDK) as a key driver of neolymphangiogenesis and metastasis (Olmeda et al, 2017). The gene discussed is MDK; the disease is melanoma.